Kanabo Group PLC (LON:KNB) has secured a second supply agreement for its VapePod medicinal cannabis inhalation device.
Under a new contract, Polish cannabis cultivation group PharmaCann will supply cartridges of medicinal cannabis based on Kanabo's proprietary formulation for the VapePod device.
READ: Kanabo higher as it signs first UK distribution agreement
Up to 36,000 cartridges per month will be filled and prepared at PharmaCann’s facility in North Macedonia as part of the new agreement, Kanabo said.
Tel Aviv-based Kanabo raised £6mln in its IPO on the London Stock Exchange last month, part of a swathe of new cannabis companies listing in the UK, including MGC Pharmaceuticals PLC (LON:MXC ASX:MXC) and Cellular Goods PLC (LON:CBX).
Kanabo chief executive Avihu Tamir said: “Following the increased fund-raise achieved at the IPO, we are able to accelerate preparations for supply of medicinal cannabis products in addition to building our CBD Wellness business.”